Nahed El-Enany
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nahed El-Enany has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Fathallah Belal
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy Mansoura University Mansoura Egypt
25 shared publications M. I. Walash
Department of Analytical Chemistry, Faculty of Pharmacy , University of Mansoura , Mansoura , Egypt
8 shared publicationsM I Walash
Department of Analytical Chemistry, Faculty of Pharmacy, University of Mansoura, Mansoura, Egypt
5 shared publications- Mahmoud El-Maghrabey
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia
5 shared publications - Mohamed Ibrahim Walash
Department of Analytical Chemistry, Faculty of Pharmacy, University of Mansoura, Mansoura, 35516, Egypt.
5 shared publications - Heba Elmansi
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy Mansoura University Mansoura Egypt
4 shared publications
Latest Publications
- Open Access
- 5 October 2017
- Published by Springer Nature in BMC Chemistry
- Vol. 11 (1) , 99
Simultaneous determination of cetirizine, phenyl propanolamine and nimesulide using third derivative spectrophotometry and high performance liquid chromatography in pharmaceutical preparations
The combination between cetirizine (CET), phenylpropanolamine (PPA) and nimesulide (NMS) under trade name Nemeriv Cp tablet is prescribed for nasal congestion, cold, sneezing, and allergy. Among all published methods for the three drugs; there is no reported method concerning estimation of CTZ, PPA and NMS simultaneously and this motivates us to develop new and simple methods for their assay in pure form and tablet preparations. Two new methodologies were described for the simultaneous quantification of cetirizine (CTZ), PPA and NMS. Spectrophotometric procedures relies on measuring the amplitudes of the third derivative curves at 238 nm for CTZ, 218 nm for PPA and 305 nm for NMS. The calibration graphs were rectilinear over the ranges of 8–90 µg/mL for CTZ, 20–100 µg/mL for PPA and 20–200 µg/mL for NMS respectively. Regarding the HPLC method; monolithic column (100 mm × 4.6 mm i.d) was used for the separation. The used mobile phase composed of 0.1 M phosphate buffer and methanol in the ratio of 40:60, v/v at pH 7.0. The analysis was performed using UV detector at 215 nm. Calibration curves showed the linearity over concentration ranges of 5–40, 10–100 and 10–120 µg/mL for CTZ, PPA and NMS. Application of the proposed methods to the laboratory prepared tablets was carried out successfully. The results were compared with those obtained from previously published methods and they were satisfactory. Graphical abstract Graphical abstract represents the chemical structures, representative chromatogram for the HPLC separation of a PPA, b NMS and c CTZ and third derivative absorption spectra of a PPA, b NMS and c CTZ for the spectrophotometric method.
- 5 October 2017
- Published by Springer Nature in BMC Chemistry
- Vol. 11 (1) , 99
Open AccessSimultaneous determination of cetirizine, phenyl propanolamine and nimesulide using third derivative spectrophotometry and high performance liquid chromatography in pharmaceutical preparations
The combination between cetirizine (CET), phenylpropanolamine (PPA) and nimesulide (NMS) under trade name Nemeriv Cp tablet is prescribed for nasal congestion, cold, sneezing, and allergy. Among all published methods for the three drugs; there is no reported method concerning estimation of CTZ, PPA and NMS simultaneously and this motivates us to develop new and simple methods for their assay in pure form and tablet preparations. Two new methodologies were described for the simultaneous quantification of cetirizine (CTZ), PPA and NMS. Spectrophotometric procedures relies on measuring the amplitudes of the third derivative curves at 238 nm for CTZ, 218 nm for PPA and 305 nm for NMS. The calibration graphs were rectilinear over the ranges of 8–90 µg/mL for CTZ, 20–100 µg/mL for PPA and 20–200 µg/mL for NMS respectively. Regarding the HPLC method; monolithic column (100 mm × 4.6 mm i.d) was used for the separation. The used mobile phase composed of 0.1 M phosphate buffer and methanol in the ratio of 40:60, v/v at pH 7.0. The analysis was performed using UV detector at 215 nm. Calibration curves showed the linearity over concentration ranges of 5–40, 10–100 and 10–120 µg/mL for CTZ, PPA and NMS. Application of the proposed methods to the laboratory prepared tablets was carried out successfully. The results were compared with those obtained from previously published methods and they were satisfactory. Graphical abstract Graphical abstract represents the chemical structures, representative chromatogram for the HPLC separation of a PPA, b NMS and c CTZ and third derivative absorption spectra of a PPA, b NMS and c CTZ for the spectrophotometric method.
- Open Access
- 30 September 2014
- Published by CIRWOLRD in JOURNAL OF ADVANCES IN CHEMISTRY
- Vol. 10 (6) , 2796-2813
Validated Sensitive Spectrophotometric methods for Determination of Carvedilol and Nebivolol HCl in dosage forms.
A simple, sensitive and rapid spectrophotometric methods were developed and validated for the determination of two antihypertensive drugs namely, carvedilol and nebivolol hydrochloride in pure form and pharmaceutical formulations. Method (I) is based on the formation of a binary complex between the studied drugs and eosin Y in presence of tween 80 at (pH 3.0).The formed complex exhibited maximum absorption at 545 nm for carvedilol and 543 nm for nebivolol. The concentration plots were rectilinear over concentration range of 0.5-5 and 1-7 µg/mL with lower detection limits of 0.09 and 0.11µg/mL and lower quantitation limits of 0.28 and 0 .34 µg/mL for carvedilol and nebivolol respectively. Method (II) is based on the reaction of studied drugs through their secondary amino groups with 2, 4-dinitrofluorobenzene (DNFB) at pH 8 to form yellow colored reaction products peaking at 383 nm and 390 nm for carvedilol and nebivolol, respectively. The absorbance-concentration plots were rectilinear over the concentration ranges of 5-30 and 4-28 µg/ mLwith the lower detection limits of 0.48 and 0.51 µg/mL and the lower quantitation limits of 1.45 and 1.54 µg/mL for cavredilol and nebivolol respectively. The different experimental parameters affecting the development and stability of the formed complex and reaction products were carefully studied and optimized for both methods. Both methods were successfully applied for determination of the studied drugs in their dosage forms.
- 30 September 2014
- Published by CIRWOLRD in JOURNAL OF ADVANCES IN CHEMISTRY
- Vol. 10 (6) , 2796-2813
Open AccessValidated Sensitive Spectrophotometric methods for Determination of Carvedilol and Nebivolol HCl in dosage forms.
A simple, sensitive and rapid spectrophotometric methods were developed and validated for the determination of two antihypertensive drugs namely, carvedilol and nebivolol hydrochloride in pure form and pharmaceutical formulations. Method (I) is based on the formation of a binary complex between the studied drugs and eosin Y in presence of tween 80 at (pH 3.0).The formed complex exhibited maximum absorption at 545 nm for carvedilol and 543 nm for nebivolol. The concentration plots were rectilinear over concentration range of 0.5-5 and 1-7 µg/mL with lower detection limits of 0.09 and 0.11µg/mL and lower quantitation limits of 0.28 and 0 .34 µg/mL for carvedilol and nebivolol respectively. Method (II) is based on the reaction of studied drugs through their secondary amino groups with 2, 4-dinitrofluorobenzene (DNFB) at pH 8 to form yellow colored reaction products peaking at 383 nm and 390 nm for carvedilol and nebivolol, respectively. The absorbance-concentration plots were rectilinear over the concentration ranges of 5-30 and 4-28 µg/ mLwith the lower detection limits of 0.48 and 0.51 µg/mL and the lower quantitation limits of 1.45 and 1.54 µg/mL for cavredilol and nebivolol respectively. The different experimental parameters affecting the development and stability of the formed complex and reaction products were carefully studied and optimized for both methods. Both methods were successfully applied for determination of the studied drugs in their dosage forms.
- 6 January 2014
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 7 (14) , 5954-5961
Spectroscopic studies on naftazone and its metal complexes with analytical applications for quality control of tablets
The spectroscopic characteristics of the haemostatic drug naftazone as well as its metal complexing ability were investigated spectrophotometrically in order to develop new, simple and sensitive spectrophotometric methods for its determination.
- 6 January 2014
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 7 (14) , 5954-5961
Spectroscopic studies on naftazone and its metal complexes with analytical applications for quality control of tablets
The spectroscopic characteristics of the haemostatic drug naftazone as well as its metal complexing ability were investigated spectrophotometrically in order to develop new, simple and sensitive spectrophotometric methods for its determination.
- Open Access
- 1 October 2013
- Published by Springer Nature in BMC Chemistry
- Vol. 7 (1) , 162
Micellar liquid chromatographic method for the simultaneous determination of Levofloxacin and Ambroxol in combined tablets: Application to biological fluids
Background: Levofloxacin hemihydrate (LEV) and ambroxol HCl (AMB) are available for the treatment of upper and lower respiratory tract infections. A survey of the literature reveals that two reversed phase HPLC methods were e reported for the simultaneous determination of LEV and AMB in pharmaceutical preparations. However the reported methods suffers from the low sensitivity, no application of the method in the combined tablets and no application to biological fluids. Also the toxic effects of the used solvents which are harmful to human beings. For this reason, our target was to develop a simple sensitive, less hazardous micellar HPLC method for the simultaneous determination of LEV and AMB in their combined dosage forms and plasma. Results: The method showed good linearity over the ranges of 1–44 μg/mL and 1–20 μg/mL with limits of detection 0.26 and 0.07 μg/mL and limits of quantification 0.80 and 0.20 μg/mL for LEV and AMB, respectively. The method was further extended to the determination of LEV in spiked human plasma with mean percentage recoveries of 100.10% ± 1.14 as well as determination of LEV in real human plasma without prior extraction. Statistical evaluation of the data was performed according to ICH Guidelines. Conclusion: The suggested method was successfully applied for the simultaneous analysis of the studied drugs in their co-formulated tablets and human plasma. The mean percentage recoveries in combined tablets were 100.20 ± 1.64 and 100.72 ± 1.11 for LEV and AMB, respectively and 100.10 ± 1.14 for LEV in spiked human plasma. Statistical comparison of the results with those of the comparison method revealed good agreement and proved that there were no significant difference in the accuracy and precision between the two methods respectively.
- 1 October 2013
- Published by Springer Nature in BMC Chemistry
- Vol. 7 (1) , 162
Open AccessMicellar liquid chromatographic method for the simultaneous determination of Levofloxacin and Ambroxol in combined tablets: Application to biological fluids
Background: Levofloxacin hemihydrate (LEV) and ambroxol HCl (AMB) are available for the treatment of upper and lower respiratory tract infections. A survey of the literature reveals that two reversed phase HPLC methods were e reported for the simultaneous determination of LEV and AMB in pharmaceutical preparations. However the reported methods suffers from the low sensitivity, no application of the method in the combined tablets and no application to biological fluids. Also the toxic effects of the used solvents which are harmful to human beings. For this reason, our target was to develop a simple sensitive, less hazardous micellar HPLC method for the simultaneous determination of LEV and AMB in their combined dosage forms and plasma. Results: The method showed good linearity over the ranges of 1–44 μg/mL and 1–20 μg/mL with limits of detection 0.26 and 0.07 μg/mL and limits of quantification 0.80 and 0.20 μg/mL for LEV and AMB, respectively. The method was further extended to the determination of LEV in spiked human plasma with mean percentage recoveries of 100.10% ± 1.14 as well as determination of LEV in real human plasma without prior extraction. Statistical evaluation of the data was performed according to ICH Guidelines. Conclusion: The suggested method was successfully applied for the simultaneous analysis of the studied drugs in their co-formulated tablets and human plasma. The mean percentage recoveries in combined tablets were 100.20 ± 1.64 and 100.72 ± 1.11 for LEV and AMB, respectively and 100.10 ± 1.14 for LEV in spiked human plasma. Statistical comparison of the results with those of the comparison method revealed good agreement and proved that there were no significant difference in the accuracy and precision between the two methods respectively.
- 10 January 2013
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 36 (4) , 439-453
SIMULTANEOUS DETERMINATION OF METOCLOPRAMIDE HYDROCHLORIDE AND PYRIDOXINE HYDROCHLORIDE IN SYRUP USING HPLC METHOD WITH FLUORESCENCE DETECTION: APPLICATION TO HUMAN PLASMA
A simple, sensitive, and rapid HPLC method was developed and validated for the simultaneous determination of metoclopramide hydrochloride (MCA) and pyridoxine hydrochloride (PDX). The analysis was carried out on CLC Shim-pack C8 column (250 × 4.6 mm, 5 µm particle size) using a mobile phase consisting of methanol:0.02 M phosphate buffer mixture (45:55, v/v) of pH 3.0. The mobile phase was pumped at a flow rate of 1 mL/min with fluorescence detection at 308/374 nm. The method showed good linearity over the concentration ranges of 0.004–0.20 and 0.05–1.0 µg/mL for MCA and PDX, respectively, with limits of detection of 0.9 and 11.2 ng/mL. The proposed method was applied for the simultaneous determination of the two studied drugs in their combined syrup with average % recoveries of 100.31 ± 1.19 and 99.63 ± 1.27 for MCA and PDX, respectively. By virtue of its high sensitivity, the developed method was further applied to the determination of MCA in human plasma with mean % recovery of 101.00 ± 7.00.
- 10 January 2013
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 36 (4) , 439-453
SIMULTANEOUS DETERMINATION OF METOCLOPRAMIDE HYDROCHLORIDE AND PYRIDOXINE HYDROCHLORIDE IN SYRUP USING HPLC METHOD WITH FLUORESCENCE DETECTION: APPLICATION TO HUMAN PLASMA
A simple, sensitive, and rapid HPLC method was developed and validated for the simultaneous determination of metoclopramide hydrochloride (MCA) and pyridoxine hydrochloride (PDX). The analysis was carried out on CLC Shim-pack C8 column (250 × 4.6 mm, 5 µm particle size) using a mobile phase consisting of methanol:0.02 M phosphate buffer mixture (45:55, v/v) of pH 3.0. The mobile phase was pumped at a flow rate of 1 mL/min with fluorescence detection at 308/374 nm. The method showed good linearity over the concentration ranges of 0.004–0.20 and 0.05–1.0 µg/mL for MCA and PDX, respectively, with limits of detection of 0.9 and 11.2 ng/mL. The proposed method was applied for the simultaneous determination of the two studied drugs in their combined syrup with average % recoveries of 100.31 ± 1.19 and 99.63 ± 1.27 for MCA and PDX, respectively. By virtue of its high sensitivity, the developed method was further applied to the determination of MCA in human plasma with mean % recovery of 101.00 ± 7.00.
- 13 August 2012
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 35 (14) , 2021-2041
STABILITY-INDICATING HPLC METHOD WITH FLUORESCENCE DETECTION FOR DETERMINATION OF METHOCARBAMOL IN TABLETS. APPLICATION TO THERAPEUTIC DRUG MONITORING
A simple and highly sensitive stability-indicating HPLC method was developed and validated for the determination of the muscle relaxant, methocarbamol (MTC), in presence of its degradation product, guaifenesin (GFS). The analyses were carried out on a Nucleosil 100-5 phenyl column (4.6 × 250 mm, 5 µm particle size), using a mobile phase consisting of 0.02 M orthophosphoric acid/ acetonitrile mixture (80:20, v/v) of pH 5.0 at a flow rate of 1 mL/min with fluorescence detection at 277/313 nm. The method showed good linearity for MTC over the concentration range of 0.02–0.50 µg/mL with lower detection limit of 4.5 ng/mL and lower quantification limit of 14.0 ng/mL. The proposed method allowed the detection of GFS in MTC drug substance, as a potential impurity and degradation product, within the pharmacopeial limit specified by the USP. The proposed method was successfully applied for the determination of MTC in different pharmaceutical formulations without interference from coformulated drugs. Statistical comparison of the results obtained with those of the official method revealed no significance differences in the performance of the two methods regarding accuracy and precision. Moreover, the proposed method was applied for the therapeutic drug monitoring of MTC in human plasma.
- 13 August 2012
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 35 (14) , 2021-2041
STABILITY-INDICATING HPLC METHOD WITH FLUORESCENCE DETECTION FOR DETERMINATION OF METHOCARBAMOL IN TABLETS. APPLICATION TO THERAPEUTIC DRUG MONITORING
A simple and highly sensitive stability-indicating HPLC method was developed and validated for the determination of the muscle relaxant, methocarbamol (MTC), in presence of its degradation product, guaifenesin (GFS). The analyses were carried out on a Nucleosil 100-5 phenyl column (4.6 × 250 mm, 5 µm particle size), using a mobile phase consisting of 0.02 M orthophosphoric acid/ acetonitrile mixture (80:20, v/v) of pH 5.0 at a flow rate of 1 mL/min with fluorescence detection at 277/313 nm. The method showed good linearity for MTC over the concentration range of 0.02–0.50 µg/mL with lower detection limit of 4.5 ng/mL and lower quantification limit of 14.0 ng/mL. The proposed method allowed the detection of GFS in MTC drug substance, as a potential impurity and degradation product, within the pharmacopeial limit specified by the USP. The proposed method was successfully applied for the determination of MTC in different pharmaceutical formulations without interference from coformulated drugs. Statistical comparison of the results obtained with those of the official method revealed no significance differences in the performance of the two methods regarding accuracy and precision. Moreover, the proposed method was applied for the therapeutic drug monitoring of MTC in human plasma.
- 7 August 2012
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 35 (13) , 1779-1797
RATIO DERIVATIVE SPECTROPHOTOMETRIC AND MICELLAR LIQUID CHROMATOGRAPHIC METHODS FOR THE SIMULTANEOUS DETERMINATION OF HYDROCHLOROTHIAZIDE AND PINDOLOL IN PHARMACEUTICAL PREPARATIONS
Two simple and accurate analytical methods were developed for the resolution and analysis of a binary mixture of hydrochlorothiazide (HCT) and pindolol (PIN), based on using a ratio derivative spectrophotometric technique and a micellar liquid chromatographic method. The first method depends on measuring the amplitudes of the first derivative of the ratio spectra at 337.2 nm for HCT and 294.4 nm for PIN. The calibration graphs were linear over the range of 5–40 µg/mL for HCT and 2–32 µg/mL for PIN. For the second method, good chromatographic separation was achieved using a 250 mm × 4.6 mm i.d., 5 µm particle size Symmetry C18 column. Mobile phase containing 0.15 M sodium dodecyl sulfate, 0.3% triethylamine, and 18% methanol in 0.02 M orthophosphoric acid of pH 3.0 was pumped at a flow rate of 1 mL/min with UV detection at 254 nm. Indapamide (IND) was used as an internal standard (IS). The method showed good linearity over the concentration ranges of 2–30 µg/mL and 2–40 µg/mL with limits of detection of 0.54 and 0.49 µg/mL and limits of quantification of 1.82 and 1.64 µg/mL for HCT and PIN, respectively. The suggested methods were successfully applied for the simultaneous analysis of the studied drugs in their synthetic mixtures and coformulated tablets. The second method was also applied for the determination of the studied drugs in presence of some co-administered drugs such as atorvastatin, propranolol, enalapril, temocapril, nicardipine, xipamide, and chlothalidone without any interference.
- 7 August 2012
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 35 (13) , 1779-1797
RATIO DERIVATIVE SPECTROPHOTOMETRIC AND MICELLAR LIQUID CHROMATOGRAPHIC METHODS FOR THE SIMULTANEOUS DETERMINATION OF HYDROCHLOROTHIAZIDE AND PINDOLOL IN PHARMACEUTICAL PREPARATIONS
Two simple and accurate analytical methods were developed for the resolution and analysis of a binary mixture of hydrochlorothiazide (HCT) and pindolol (PIN), based on using a ratio derivative spectrophotometric technique and a micellar liquid chromatographic method. The first method depends on measuring the amplitudes of the first derivative of the ratio spectra at 337.2 nm for HCT and 294.4 nm for PIN. The calibration graphs were linear over the range of 5–40 µg/mL for HCT and 2–32 µg/mL for PIN. For the second method, good chromatographic separation was achieved using a 250 mm × 4.6 mm i.d., 5 µm particle size Symmetry C18 column. Mobile phase containing 0.15 M sodium dodecyl sulfate, 0.3% triethylamine, and 18% methanol in 0.02 M orthophosphoric acid of pH 3.0 was pumped at a flow rate of 1 mL/min with UV detection at 254 nm. Indapamide (IND) was used as an internal standard (IS). The method showed good linearity over the concentration ranges of 2–30 µg/mL and 2–40 µg/mL with limits of detection of 0.54 and 0.49 µg/mL and limits of quantification of 1.82 and 1.64 µg/mL for HCT and PIN, respectively. The suggested methods were successfully applied for the simultaneous analysis of the studied drugs in their synthetic mixtures and coformulated tablets. The second method was also applied for the determination of the studied drugs in presence of some co-administered drugs such as atorvastatin, propranolol, enalapril, temocapril, nicardipine, xipamide, and chlothalidone without any interference.
- Open Access
- 1 June 2012
- Published by Akademiai Kiado Zrt. in Acta Chromatographica
- Vol. 24 (2) , 185-206
Simultaneous determination of celiprolol HCl and chlorthalidone in tablets and biological fluids using high-performance liquid chromatography
Summary A simple, accurate, and sensitive reversed-phase HPLC method was developed for the simultaneous determination of celiprolol HCl (CE) and chlorthalidone (CT). Good chromatographic separation was achieved using a 250 mm × 4.6 mm i.d., 5 μm particle size Hypurity C8 column. Mobile phase containing a mixture of methanol and 0.04 M phosphate buffer (35:65, υ/υ) at pH 7.0 was pumped at a flow rate of 1.2 mL min−1 with UV detection at 225 nm. Lisinopril dihydrate (LIS) was used as internal standard. The method showed good linearity in the ranges 0.2–20 and 0.2–10 μg mL−1 with limits of detection 0.06 and 0.04 μg mL−1 and limits of quantification 0.20 and 0.14μg mL−1 for CE and CT, respectively. The suggested method was successfully applied to the simultaneous analysis of the studied drugs in their synthetic mixture and coformulated tablet. The method was further extended to the determination of CE in biological fluids. The proposed method was also applied to the determination of the studied drugs in presence of some coadministered or related drugs such as atenolol, propranolol, acetazolamide, enalapril, nicardipine, triamterene, and hydrochlorothiazide without any interference.
- 1 June 2012
- Published by Akademiai Kiado Zrt. in Acta Chromatographica
- Vol. 24 (2) , 185-206
Open AccessSimultaneous determination of celiprolol HCl and chlorthalidone in tablets and biological fluids using high-performance liquid chromatography
Summary A simple, accurate, and sensitive reversed-phase HPLC method was developed for the simultaneous determination of celiprolol HCl (CE) and chlorthalidone (CT). Good chromatographic separation was achieved using a 250 mm × 4.6 mm i.d., 5 μm particle size Hypurity C8 column. Mobile phase containing a mixture of methanol and 0.04 M phosphate buffer (35:65, υ/υ) at pH 7.0 was pumped at a flow rate of 1.2 mL min−1 with UV detection at 225 nm. Lisinopril dihydrate (LIS) was used as internal standard. The method showed good linearity in the ranges 0.2–20 and 0.2–10 μg mL−1 with limits of detection 0.06 and 0.04 μg mL−1 and limits of quantification 0.20 and 0.14μg mL−1 for CE and CT, respectively. The suggested method was successfully applied to the simultaneous analysis of the studied drugs in their synthetic mixture and coformulated tablet. The method was further extended to the determination of CE in biological fluids. The proposed method was also applied to the determination of the studied drugs in presence of some coadministered or related drugs such as atenolol, propranolol, acetazolamide, enalapril, nicardipine, triamterene, and hydrochlorothiazide without any interference.
- 29 March 2012
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 35 (6) , 819-833
HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHY: A WORTHY TECHNIQUE FOR THE DETERMINATION OF LAMOTRIGINE IN TABLETS AND HUMAN PLASMA
A rapid, stability indicating hydrophilic interaction liquid chromatography (HILIC) method was developed for the determination of lamotrigine and its induced alkaline degradation product. The separation was performed on an unmodified silica column adopting UV detection at 290 nm with flow rate of 1.5 mL min−1. The mobile phase consisted of a mixture of acetonitrile:ammonium formate 0.01 M (85: 15, v/v) and the pH was adjusted at 5.0. The method showed good linearity in the range of 0.5-10 µg mL−1 with lower limit of detection (LOD) 0.1 µg mL−1 and limit of quantification (LOQ) 0.5 µg mL−1, respectively. The proposed method was applied to tablets assay and was further extended to the in vitro and in vivo determination of the drug in spiked and real human plasma. The mean percentage recoveries were 100.32 ± 2.59 (n = 3) and 95.63 ± 4.42 (n = 3), respectively. Kinetics for the stability study was performed.
- 29 March 2012
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 35 (6) , 819-833
HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHY: A WORTHY TECHNIQUE FOR THE DETERMINATION OF LAMOTRIGINE IN TABLETS AND HUMAN PLASMA
A rapid, stability indicating hydrophilic interaction liquid chromatography (HILIC) method was developed for the determination of lamotrigine and its induced alkaline degradation product. The separation was performed on an unmodified silica column adopting UV detection at 290 nm with flow rate of 1.5 mL min−1. The mobile phase consisted of a mixture of acetonitrile:ammonium formate 0.01 M (85: 15, v/v) and the pH was adjusted at 5.0. The method showed good linearity in the range of 0.5-10 µg mL−1 with lower limit of detection (LOD) 0.1 µg mL−1 and limit of quantification (LOQ) 0.5 µg mL−1, respectively. The proposed method was applied to tablets assay and was further extended to the in vitro and in vivo determination of the drug in spiked and real human plasma. The mean percentage recoveries were 100.32 ± 2.59 (n = 3) and 95.63 ± 4.42 (n = 3), respectively. Kinetics for the stability study was performed.
- 24 February 2012
- Published by Wiley in Luminescence
- Vol. 27 (6) , 511-518
Spectrofluorimetric determination of oseltamivir phosphate through derivatization with o‐phthalaldehyde. Application to pharmaceutical preparations with a preliminary study on spiked plasma samples
A simple and sensitive spectrofluorimetric method has been developed and validated for the determination of oseltamivir phosphate (OST) in pharmaceutical preparations. The method is based on the reaction between oseltamivir phosphate and o‐phthalaldehyde in presence of 2‐mercapto‐ethanol in borate buffer, pH 10.8, to give a highly fluorescent product measured at 450 nm after excitation at 336 nm. The different experimental parameters affecting the development and stability of the reaction product were studied and optimized. The fluorescence intensity–concentration plot is rectilinear over the range 0.05–1.0 µg/mL, with a lower detection limit of 5 ng/mL and limit of quantitation of 16 ng/mL. The developed method was successfully applied to the analysis of the drug in its commercial capsules and suspension, mean recoveries of OST were 99.97 ± 1.67% and 100.17 ± 1.18%, respectively (n = 3). Statistical comparison of the results obtained by the proposed and comparison method revealed no significant difference in the performance of the two methods regarding accuracy and precision. The proposed method was further extended to in vitro determination of the studied drug in spiked human plasma as a preliminary investigation; the mean recovery (n = 3) was 98.68 ± 5.8%. A reaction pathway was postulated. Copyright © 2012 John Wiley & Sons, Ltd.
- 24 February 2012
- Published by Wiley in Luminescence
- Vol. 27 (6) , 511-518
Spectrofluorimetric determination of oseltamivir phosphate through derivatization with o‐phthalaldehyde. Application to pharmaceutical preparations with a preliminary study on spiked plasma samples
A simple and sensitive spectrofluorimetric method has been developed and validated for the determination of oseltamivir phosphate (OST) in pharmaceutical preparations. The method is based on the reaction between oseltamivir phosphate and o‐phthalaldehyde in presence of 2‐mercapto‐ethanol in borate buffer, pH 10.8, to give a highly fluorescent product measured at 450 nm after excitation at 336 nm. The different experimental parameters affecting the development and stability of the reaction product were studied and optimized. The fluorescence intensity–concentration plot is rectilinear over the range 0.05–1.0 µg/mL, with a lower detection limit of 5 ng/mL and limit of quantitation of 16 ng/mL. The developed method was successfully applied to the analysis of the drug in its commercial capsules and suspension, mean recoveries of OST were 99.97 ± 1.67% and 100.17 ± 1.18%, respectively (n = 3). Statistical comparison of the results obtained by the proposed and comparison method revealed no significant difference in the performance of the two methods regarding accuracy and precision. The proposed method was further extended to in vitro determination of the studied drug in spiked human plasma as a preliminary investigation; the mean recovery (n = 3) was 98.68 ± 5.8%. A reaction pathway was postulated. Copyright © 2012 John Wiley & Sons, Ltd.